Research/art/teacher profile of a person
Name and surname:
doc. Mgr. Tatiana Burjanivová, PhD.
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Burjanivová
I.2 - Name
Tatiana
I.3 - Degrees
Doc. Mgr. PhD.
I.4 - Year of birth
1979
I.5 - Name of the workplace
Department of Molecular Biology and Genomics
I.6 - Address of the workplace
Malá Hora 1161/4C, 03601 Martin
I.7 - Position
Associate professor
I.8 - E-mail address
tatiana.burjanivova@uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/5386
I.10 - Name of the study field in which a person works at the university
general medicine

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.a - Name of the university or institution
Faculty of Natural Science, Comenius University
II.b - Year
2002
II.c - Study field and programme
Biology,Genetics
II.2 - Second degree of higher education
II.a - Name of the university or institution
The 2nd Faculty of Medicine of Charles University in Prague
II.b - Year
2007
II.c - Study field and programme
Molecular and Cellular Biology, Genetics and Virology
II.3 - Third degree of higher education
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Medicine and Dentistry, Palacký University Olomouc
II.b - Year
2020
II.c - Study field and programme
Medical Biology
II.5 - Professor
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
associate professor Jessenius Faculty of Medicine CU in Martin 01.02.2021-up to now 
teaching assistant Jessenius Faculty of Medicine CU in Martin 1.9.2008-31.1.2021
researcher Jessenius Faculty of Medicine CU in Martin 1.8.2014-31.1.2015
researcher The Martin University Hospital 15.1.2007-31.8.2008

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
First Certificate in English University of Cambridge SOL Examinations 2004
Team based learning course Faculty of Medicine in Bratislava 2018
Private english lessons Hana Jesenská 2020
Private english lessons Hana Jesenská 2021
BASICS OF BIOINFORMATICS AJ ty v IT 2022

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Molecular Biology General medicine I.+II. General medicine
Laboratory practicals in molecular biology General medicine I.+II. General medicine
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.2.a - Name of the study programme V.2.b - Degree V.2.c - Field of study
general medicine I.+II. general medicine
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
1
V.4.2 - Number of defended theses
V.4.b - Diploma (second degree)
3
V.4.c - Dissertation (third degree)
2
V.5 - Overview of other courses taught in the current academic year according to study programmes

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
108
VI.1.b - Over the last six years
33
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
33
VI.1.b - Over the last six years
14
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
157
VI.1.b - Over the last six years
91
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
143
VI.1.b - Over the last six years
87
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
0
VI.1.b - Over the last six years
0
VI.2 - The most significant research/artistic/other outputs
1

Milosevic JD., Puda A., Malcovati L., Berg T., Hofbauer M., Stukalov A., Klampfl T., Harutyunyan AS., Gisslinger H., Gisslinger B., Burjanivova T., Rumi E., Pietra D., Elena C., Vannucchi AM., Doubek M., Dvorakova D., Robesova B., Wieser R., Koller E., Suvajdzic N., Tomin D., Tosic N., Colinge J., Racil Z., Steurer M., Pavlovic S., Cazzola M., Kralovics R. Clinical significance of genetic aberrations in secondary acute myeloid leukemia. Am J Hematol. 2012 Nov;87(11):1010-6. Number of citations: 61

2

Tashi T., Scott Reading N., Wuren T., Zhang X., Moore LG., Hu H., Tang F, Shestakova A., Lorenzo F., Burjanivova T., Koul P., Guchhait P., Wittwer CT., Julian CG., Shah B., Huff CD., Gordeuk VR., Prchal JT., Ge R. Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders. J Mol Med (Berl). 2017 Jun;95(6):665-670. Number of citations: 56

3

Zuna J*., Burjanivova T*., Mejstrikova E., Zemanova Z., Muzikova K., Meyer C., Horsley SW., Kearney L., Colman S., Ptoszkova H., Marschalek R., Hrusak O., Stary J., Greaves M., Trka J. Covert preleukemia driven by MLL gene fusion. Genes Chromosomes Cancer. 2009 Jan;48(1):98-107. Number of citations: 15

4

Nussenzveig RH*., Burjanivova T*., Salama ME., Ogilvie NW., Marcinek J., Plank L., Agarwal AM., Perkins SL., Prchal JT. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera. Leuk Lymphoma. 2012 Dec;53(12):2479-86. Number of citations: 12

5

Lanikova L., Reading NS., Hu H., Tashi T., Burjanivova T., Shestakova A., Siwakoti B., Thakur BK., Pun CB., Sapkota A., Abdelaiz S., Feng BJ., Huff CD., Hasibe M., Prchal JT. Evolutionary selected Tibetan variants of HIF pathway and risk of lung cancer. Oncotarget. 2017 Feb 14;8(7):11739-11747.Number of citations: 13

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Lukáčová E, Pös O, Túryová E, Hurtová T, Hanzlíková Z, Szemes T, Burjanivová T. Copy number variations in malignant melanoma: genomic regions, biomarkers, and therapeutic targets.  Neoplasma. 2024 Apr;71(2):143-152.

2

Lukacova E, Burjanivova T, Podlesniy P, Grendar M, Turyova E, Kasubova I, Laca L, Mikolajcik P, Kudelova E, Vanochova A, Miklusica J, Mersakova S, Lasabova Z. Hypermethylated GRIA, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer. Front Oncol. 2023 Jul 5;13:1205791. Number of citations: 4

3

Burjanivova T, Lukacova E, Lucansky V, Samec M, Podlesniy P, Kolkova Z, Reizigova L, Grendar M, Turyova E, Holubekova V, Malicherova B, Nosal V, Kasubova I, Dusenka R, Osinova D, Hosalova Matisova J, Dvorska D, Brany D, Dankova Z, Novakova E, Calkovska A, Halasova E. Sensitive SARS-CoV-2 detection, air travel Covid-19 testing, variant determination and fast direct PCR detection, using ddPCR and RT-qPCR methods. Acta Virol. 2023;67(1):3-12. Number of citations: 4.

4

Lucansky V, Samec M, Burjanivova T, Lukacova E, Kolkova Z, Holubekova V, Turyova E, Hornakova A, Zaborsky T, Podlesniy P, Reizigova L, Dankova Z, Novakova E, Pecova R, Calkovska A, Halasova E. Comparison of the methods for isolation and detection of SARS-CoV-2 RNA in municipal wastewater.Front Public Health. 2023 Mar 7;11:1116636. Number of citations: 7.

5

Péčová T, Burjanivová T, Malicherová B, Péč MJ, Rohoň I, Madleňák M, Adamicová K, Péč J. Newly Developed Psoriasis in a Patient with Telangiectasia Macularis Eruptiva Perstans and Systemic Mastocytosis Treated with Interferon. Case Rep Dermatol. 2021 Dec 7;13(3):558-562. Number of citations: 1.

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

Milosevic JD., Puda A., Malcovati L., Berg T., Hofbauer M., Stukalov A., Klampfl T., Harutyunyan AS., Gisslinger H., Gisslinger B., Burjanivova T., Rumi E., Pietra D., Elena C., Vannucchi AM., Doubek M., Dvorakova D., Robesova B., Wieser R., Koller E., Suvajdzic N., Tomin D., Tosic N., Colinge J., Racil Z., Steurer M., Pavlovic S., Cazzola M., Kralovics R. Clinical significance of genetic aberrations in secondary acute myeloid leukemia. Am J Hematol. 2012 Nov;87(11):1010-6.

2

Burjanivova T., Madzo J., Muzikova K., Meyer C., Schneider B., Votava F., Marschalek R., Stary J., Trka J., Zuna J. Prenatal origin of childhood AML occurs less frequently than in childhood ALL. BMC Cancer. 2006 Apr 21;6:100. 21 citácií

3

Zuna J*., Burjanivova T*., Mejstrikova E., Zemanova Z., Muzikova K., Meyer C., Horsley SW., Kearney L., Colman S., Ptoszkova H., Marschalek R., Hrusak O., Stary J., Greaves M., Trka J. Covert preleukemia driven by MLL gene fusion. Genes Chromosomes Cancer. 2009 Jan;48(1):98-107. 10 citácií

4

Nussenzveig RH*., Burjanivova T*., Salama ME., Ogilvie NW., Marcinek J., Plank L., Agarwal AM., Perkins SL., Prchal JT. Detection of JAK2 mutations in paraffin marrow biopsies by high resolution melting analysis: identification of L611S alone and in cis with V617F in polycythemia vera. Leuk Lymphoma. 2012 Dec;53(12):2479-86. 8 citácií

5

Tashi T., Scott Reading N., Wuren T., Zhang X., Moore LG., Hu H., Tang F, Shestakova A., Lorenzo F., Burjanivova T., Koul P., Guchhait P., Wittwer CT., Julian CG., Shah B., Huff CD., Gordeuk VR., Prchal JT., Ge R. Gain-of-function EGLN1 prolyl hydroxylase (PHD2 D4E:C127S) in combination with EPAS1 (HIF-2α) polymorphism lowers hemoglobin concentration in Tibetan highlanders. J Mol Med (Berl). 2017 Jun;95(6):665-670.27 citácií

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

 Grant APVV - APVV-16-0066: Genomic profile and transcriptional signature of colorectal cancer 

Main investigator: doc. RNDr. Zora Lasabová, PhD., doba riešenia 2017-2021, co-investigator  

2

VEGA no. 1/0205/20 Profiling of circulating tumor DNA and FFPE tissues in the management, and in prognosis of patients with malignant melanomas by using next generation sequencing

3

New possibilities of laboratory diagnostics and massive screening of SARS-CoV-2 and identification of mechanisms of virus behavior in the human body (COVLAB) ITMS2014 +: 313011AUA4

4

Integrative strategy in the development of personalized medicine of selected malignant tumors and its impact on quality of life (LISPER)

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VII.a - Activity, position VII.b - Name of the institution, board VII.c - Duration
PREPMED/Interreg MIRI 2021-2023
Open Day at the Jessenius Faculty of Medicine in Martin Jessenius Faculty of Medicine 4.11.2019
Science and Technology Week in the Slovak Republic Jessenius Faculty of Medicine 9.11.2021

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

VIII.a - Name of the institution VIII.b - Address of the institution VIII.c - Duration (indicate the duration of stay) VIII.d - Mobility scheme, employment contract, other (describe)
University of Utah 2000 Cir of Hope Dr, Salt Lake City, UT 84112,USA 15. 7.2010-15.8.2010 Grant UICC International Cancer Technology Transfer Fellowship No. ICR/ 10/054 /2010
Research Center for Molecular Medicine of the Austrian Academy of Sciences Lazarettgasse 14 AKH BT 25.3 1090 Vienna Austria 15.5.2011-15.8.2011 ESF grant „ Support of human resources development using the most modern methods and forms of education at JFM CU in Martin“ (ITMS 26110230031)
University of Utah 2000 Cir of Hope Dr, Salt Lake City, UT 84112,USA 1.9.2014-30.11.2014 Grant IMTS. 26110230067: „ Career growth opportunities in research and develop- ment in the field of medical sciences".

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned


Co-investigator - Adaptor Molecules in Leukemias between 2006-2008 grant Adaptor Molecules in Leukemias was awarded for medical research by the Ministery of Health of the Czech Republic. Opponent of diploma thesis for Comenius University (tomas.szemes@uniba.sk). Opponent of diploma thesis for Charles University  (juliastarkova@gmail.com) 

Date of last update
2025-02-03